#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phaeochromocytoma Glomerulonephritis membranous Transitional cell cancer of the renal pelvis and ureter Nephropathy Amyotrophic lateral sclerosis gene carrier Congenital aplastic anaemia Thalassaemia beta Angiosarcoma metastatic Acute promyelocytic leukaemia Haemophagocytic lymphohistiocytosis Loss of consciousness Cutaneous T-cell lymphoma stage I Chronic inflammatory demyelinating polyradiculoneuropathy Autoinflammation with infantile enterocolitis Hereditary angioedema with C1 esterase inhibitor deficiency More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Trials in Disease Chordoma Shprintzen-Goldberg syndrome – Trials in Disease Angiosarcoma non-metastatic – Treatment CADASIL – Basic Information Pemphigoid Fragile X syndrome – Treatment Marginal zone lymphoma refractory – Diagnostics Myelodysplastic syndrome – Diagnostics Behcet’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Temocillin Eptinezumab Methylprednisolone Ecoo6A Adalimumab ORX750 Petosemtamab Triglycerides, Medium Chain TEV-53408 Fluticasone Propionate Streptococcus Agalactiae Diacerein Sitravatinib Malate Phenylalanine Lysine Hydrochloride Enomimeran GS-248 VALACICLOVIR HYDROCHLORIDE Ro7247669 Lurasidone More therapies…

    Learn about Your Condition

    Supraventricular tachycardia Primary adrenal insufficiency Acute on chronic liver failure Optic ischaemic neuropathy Mitochondrial DNA depletion Epileptic encephalopathy Glioblastoma Rhabdoid tumour Critical illness Epstein-Barr virus infection Neutropenia Procedural anxiety Pulmonary sarcoidosis Multiple sclerosis relapse Nasal sinus cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Sepsis

  • Study of REGN7544 for Treating Adults with Low Blood Pressure Caused by Sepsis

    Not recruiting

    2 1
    Investigated Diseases:
    • Sepsis
    • Hypotension
    Investigated Drugs:
    • REGN7544
    France

  • Study on Personalized Linezolid Dosing for Patients with Sepsis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Linezolid
    Spain

  • Study on Epirubicin and Sodium Chloride for Patients with Sepsis or Septic Shock in Intensive Care Units

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Sepsis
    • Septic shock
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Sodium Chloride
    Germany

  • Study of hydrocortisone and fludrocortisone combination versus placebo in adults with sepsis in intensive care unit to determine corticosteroid response

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Hydrocortisone Hemisuccinate
    • Fludrocortisone
    • Betamethasone
    France

  • Study on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury

    Not recruiting

    2 1
    Investigated Diseases:
    • Sepsis
    • Acute kidney injury
    Investigated Drugs:
    • Tin816
    Austria Belgium Czechia France Germany Hungary +2

  • Study on Noradrenaline and Terlipressin for Treating Septic Shock in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    • Septic shock
    Investigated Drugs:
    • Terlipressin Acetate
    • Noradrenaline Tartrate
    Spain
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!